Cerebrovascular Accidents Associated with Sorafenib in Hepatocellular Carcinoma

Report, Article English OPEN
Muhammad W. Saif; Iris Isufi; Jennifer Peccerillo; Kostas N. Syrigos;

Sorafenib is an oral angiogenetic multikinase inhibitor approved in the treatment of renal and hepatocellular carcinoma. Bleeding and venous thrombotic events have been described with angiogenetic agents but cerebrovascular accidents are rarely reported. We report two c... View more
Share - Bookmark